Skip to main content
. 2014 May 1;9(5):e94864. doi: 10.1371/journal.pone.0094864

Table 2. Discovery of candidate mutations associated with hepatocellular carcinoma in the reverse transcriptase domain of hepatitis B virus.

Amino acid change
Nucleotide mutation P ORF S ORF Location of RT domain HCC (n = 29)* Non-HCC (n = 35)* P
C294T NC (NC) T48M Space F-A 3 (10.3) 0 (0.0) 0.088
C300G NC (NC) P49R Space F-A 3 (10.3) 0 (0.0) 0.088
T555C NC (NC) F134S Space B-C 3 (10.3) 0 (0.0) 0.088
T766A S559T (rtS213T) S204R Space C-D 3 (10.3) 0 (0.0) 0.088
A799G I570V (rtI224V) NC Space C-D 6 (20.7) 0 (0.0) 0.006
T843C NC (NC) NA Domain E 9 (31.0) 4 (11.4) 0.066
T870C NC (NC) NA Domain E 4 (13.8) 0 (0.0) 0.037
T895A C620S (rtC256S) NA Space E-end 12 (41.4) 7 (20.0) 0.098
T906R NC (NC) NA Space E-end 2 (6.9) 8 (22.9) 0.097
C936T NC (NC) NA Space E-end 9 (31.0) 3 (8.6) 0.028
A942S H617Q (rtH271Q) NA Space E-end 2 (6.9) 8 (22.9) 0.097
A987G NC (NC) NA Space E-end 6 (20.7) 1 (2.9) 0.061
T1055A M655K (rtM309K) NA Space E-end 3 (10.3) 0 (0.0) 0.088
T1069A C660S (C314S) NA Space E-end 4 (13.8) 0 (0.0) 0.037
T1071C NC (NC) NA Space E-end 3 (10.3) 0 (0.0) 0.088

Abbreviations: NA, not available, NC, not changed; rt, reverse transcriptase; P, polymerase; S, surface antigen; ORF, open reading frame.

*Data are presented as n (%).